Sachin Muralidharan

Research activity per year

Modelling of Beta Cell Pathophysiology Using Stem Cell-Derived Islets
Barsby, T., Montaser, H., Lithovius, V., Ibrahim, H., Vähäkangas, E., Muralidharan, S., Chandra, V., Saarimäki-Vire, J. & Otonkoski, T., 1 Jan 2024, Pluripotent Stem Cell Therapy for Diabetes, First Edition. Piemonti, L., Odorico, J., Kieffer, T. J. .., Sordi, V. & de Koning, E. (eds.). 1st ed. ed. Springer International Publishing , p. 573-598 26 p.
Research output: Chapter in Book/Report/Conference proceeding › Chapter › Scientific › peer-review
Primate-specific ZNF808 is essential for pancreatic development in humans
Pancreatic Agenesis Gene Discovery, De Franco, E., Owens, N. D. L., Montaser, H., Wakeling, M. N., Saarimäki-Vire, J., Triantou, A., Ibrahim, H., Balboa, D., Caswell, R. C., Jennings, R. E., Kvist, J. A., Johnson, M. B., Muralidharan, S., Ellard, S., Wright, C. F., Maddirevula, S., Alkuraya, F. S., Hanley, N. A. & Flanagan, S. E. & 3 others, Otonkoski, T., Hattersley, A. T. & Imbeault, M., 2023, In: Nature Genetics. 55, p. 2075–2081 30 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File

Otonkoski _Human-specific gene regulatio
Otonkoski, T. (Project manager), Ahmala, A. S. (Participant), Albo Mejias, S. (Participant), Balboa , D. (Participant), Bassi, J. (Participant), Huhdanpää, S. (Participant), Ibrahim, H. (Participant), Khaikin, L. M. (Participant), Laitinen, A. M. (Participant), Loza Garcia, R. (Participant), Montaser, H. (Participant), Montazeri Moghadam, S. (Participant), Muralidharan, S. (Participant), Otsamo, J. H. (Participant), Ryhänen, E. (Participant), Saarimäki-Vire, J. (Participant) & Vandenbempt, V. Y. M. (Participant)
The Wellcome Trust Ltd Wellcome Trust Scientific Conferenc
01/04/2022 → 31/03/2027
Project: Other funder

Personal profile